About the California Institute for Regenerative Medicine (CIRM)

The California Institute for Regenerative Medicine (CIRM) is a funding agency established by Californians to accelerate regenerative medicine research to deliver treatments for patients with unmet medical needs. Established in 2004 through the passage of Proposition 71, CIRM was initially funded with $3 billion from the state of California to support ongoing research, and in 2020, was funded again with another $5.5 billion through Proposition 14 to continue the Agency’s important work.

CIRM has provided billions in funding to support stem cell, genetic research, and development programs in its portfolio. Through the Agency’s research, infrastructure, and education programs, CIRM aims to transform the field of regenerative medicine, stimulate economic growth, and improve the lives of diverse communities throughout the state. For more information go to cirm.ca.gov.

Synthego is honored to provide CIRM applicants and awardees with exclusive access to advanced CRISPR solutions. Synthego offers tailored support across discovery, preclinical, and clinical stages to enable a seamless transition from innovative research to impactful real-world therapies. If you are a CIRM awardee or applicant,  reach out to us  to explore your exclusive benefits with Synthego.